Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Historical EIGR trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.29% | |
Bollinger Band Squeeze | Range Contraction | 0.29% | |
Up 3 Days in a Row | Strength | 0.29% | |
Slingshot Bearish | Bearish Swing Setup | 1.85% | |
Bollinger Band Squeeze | Range Contraction | 1.85% | |
Bollinger Band Squeeze | Range Contraction | 4.10% | |
Stochastic Reached Oversold | Weakness | 4.10% | |
BB Squeeze + Lower Band Touch | Range Contraction | 4.10% | |
Lower Bollinger Band Touch | Weakness | 4.10% | |
Oversold Stochastic | Weakness | 4.10% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
20 DMA Support | 7 minutes ago |
Rose Above 20 DMA | 42 minutes ago |
Rose Above Previous Day's High | 42 minutes ago |
Up 1% | 42 minutes ago |
Rose Above 20 DMA | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/05/2021
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Hypertension Specialty Drugs Pulmonary Arterial Hypertension Hepatitis Biopharmaceuticals Orphan Disease Orphan Diseases Pulmonary Hypertension Treatment Of Hepatitis Hypoglycemia Lymphedema
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Hypertension Specialty Drugs Pulmonary Arterial Hypertension Hepatitis Biopharmaceuticals Orphan Disease Orphan Diseases Pulmonary Hypertension Treatment Of Hepatitis Hypoglycemia Lymphedema
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.99 |
52 Week Low | 6.76 |
Average Volume | 201,711 |
200-Day Moving Average | 10.02 |
50-Day Moving Average | 9.59 |
20-Day Moving Average | 8.53 |
10-Day Moving Average | 8.33 |
Average True Range | 0.46 |
ADX | 36.86 |
+DI | 16.08 |
-DI | 25.40 |
Chandelier Exit (Long, 3 ATRs ) | 8.10 |
Chandelier Exit (Short, 3 ATRs ) | 9.23 |
Upper Bollinger Band | 9.08 |
Lower Bollinger Band | 7.97 |
Percent B (%b) | 0.47 |
BandWidth | 13.10 |
MACD Line | -0.34 |
MACD Signal Line | -0.39 |
MACD Histogram | 0.0535 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.05 | ||||
Resistance 3 (R3) | 9.02 | 8.80 | 8.95 | ||
Resistance 2 (R2) | 8.80 | 8.66 | 8.82 | 8.92 | |
Resistance 1 (R1) | 8.65 | 8.57 | 8.73 | 8.68 | 8.89 |
Pivot Point | 8.43 | 8.43 | 8.47 | 8.45 | 8.43 |
Support 1 (S1) | 8.28 | 8.29 | 8.36 | 8.31 | 8.09 |
Support 2 (S2) | 8.06 | 8.20 | 8.08 | 8.06 | |
Support 3 (S3) | 7.91 | 8.06 | 8.03 | ||
Support 4 (S4) | 7.94 |